DOCSLIB.ORG

RVX-208, an Inhibitor of BET Transcriptional Regulators with Selectivity for the Second Bromodomain

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
RVX-208, an Inhibitor of BET Transcriptional Regulators with Selectivity for the Second Bromodomain RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain Sarah Picauda, Christopher Wellsa, Ildiko Felletara, Deborah Brothertona, Sarah Martina, Pavel Savitskya, Beatriz Diez-Dacalb, Martin Philpotta, Chas Bountraa, Hannah Lingarda, Oleg Fedorova, Susanne Müllera, Paul E. Brennana, Stefan Knappa,c,1, and Panagis Filippakopoulosa,b,1 aStructural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7DQ, United Kingdom; bLudwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7DQ, United Kingdom; and cTarget Discovery Institute, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7BN United Kingdom Edited by Angela M. Gronenborn, University of Pittsburgh School of Medicine, Pittsburgh, PA, and approved October 23, 2013 (received for review June 5, 2013) Bromodomains have emerged as attractive candidates for the (7), multiple myeloma (16), acute myeloid and mixed lineage development of inhibitors targeting gene transcription. Inhibitors leukemia (17), lung cancer (18), and glioblastoma (19). of the bromo and extraterminal (BET) family recently showed BET family members play an essential role in diverse cellular promising activity in diverse disease models. However, the pleio- processes, including general transcriptional elongation (20, 21), tropic nature of BET proteins regulating tissue-specific transcription replication (22), hematopoiesis (23), adipogenesis (24, 25), and has raised safety concerns and suggested that attempts should be spermatogenesis (26), suggesting that drug discovery efforts made for domain-specific targeting. Here, we report that RVX-208, should explore isoform, or even domain-specifictargeting,to a compound currently in phase II clinical trials, is a BET bromodo- avoid adverse effects of prolonged pan-BET inhibition during main inhibitor specific for second bromodomains (BD2s). Cocrystal treatment in different tissues. structures revealed binding modes of RVX-208 and its synthetic pre- The quinazolone RVX-208 (Fig. 1A) has been developed by cursor, and fluorescent recovery after photobleaching demon- Resverlogix Corporation for the treatment of cardiovascular strated that RVX-208 displaces BET proteins from chromatin. diseases associated with atherosclerosis (27, 28) and has more However, gene-expression data showed that BD2 inhibition only recently entered clinical studies on Alzheimer’s disease (29). modestly affects BET-dependent gene transcription. Our data RVX-208 is a derivative of the plant polyphenol resveratrol fi demonstrate the feasibility of speci c targeting within the BET (3,4’,5-trihydroxy-transstilbene) that leads to an increase of family resulting in different transcriptional outcomes and high- plasma levels of the high-density lipid protein ApoA1. Increasing light the importance of BD1 in transcriptional regulation. ApoA1 levels has emerged as a promising approach for the treatment of atherosclerosis (30), and recent phase IIb clinical small molecule inhibitor | epigenetics | microarray | ApoA1 trial data using RVX-208 as an ApoA1 modulator have been encouraging (28). ApoA1 expression is regulated by BET pro- romodomains (BRDs) are protein-interaction modules that teins, and chemical inhibition of BET bromodomains has been Bare selectively recruited to e-N-acetylated lysine-containing associated with ApoA1 up-regulation on transcriptional and sequences. BRDs are present in 46 diverse, mostly nuclear pro- protein levels (9, 31, 32). As a consequence, a similar mode of teins functioning as effector domains of transcriptional regu- action has also been suggested for RVX-208, but no data char- lators, chromatin modulators, and chromatin-modifying enzymes acterizing the RVX-208/BET interaction have been published so (1). BRD-containing proteins have been implicated in the de- far. The promising clinical outcome of RVX-208 trials and the velopment of many diverse diseases, and the architecture of their presumed function of RVX-208 as a BRD inhibitor prompted us acetyl-lysine binding pocket makes them attractive targets for the fi development of potent and speci c inhibitors (2, 3). All BRD Significance modules share a conserved fold comprising a left-handed helical bundle creating a deep, largely hydrophobic and aromatic bind- fi Bromo and extraterminal (BET) proteins have diverse roles in ing pocket for the speci c recognition of peptide sequences fi e – regulating tissue-speci c transcriptional programs, raising safety containing one or more -N-acetylated lysine residues (1, 4 6). concerns for their inhibition and suggesting that targeting of In particular the bromo and extraterminal (BET) proteins, specific isoforms or even specific domains within this subfamily which comprise four members in human (BRD2, BRD3, BRD4, fi is important. We report the discovery and characterization of and the testis-speci c BRDT), recently received a lot of atten- RVX-208 as a domain-selective inhibitor of BETs and provide tion after highly potent and cell-active pan-BET inhibitors were a potential mechanism of action of a clinical compound that was – developed (7 10). BETs are transcriptional regulators that identified based on phenotypic screens. control expression of genes that play key regulatory roles in cellular proliferation, cell cycle progression, and apoptosis (11, Author contributions: C.B., H.L., O.F., S. Müller, P.E.B., S.K., and P.F. designed research; S.P., 12). Dysfunction of BET proteins has been associated with the C.W., I.F., D.B., S. Martin, P.S., B.D.-D., M.P., and P.F. performed research; S.P., C.W., B.D.-D., development of aggressive tumors, such as NUT midline carci- O.F., S.K., and P.F. analyzed data; and S.K. and P.F. wrote the paper. noma (NMC). In NMC, the N-terminal bromodomains of BRD3 The authors declare no conflict of interest. or BRD4 are fused in frame with the testis-specific protein NUT This article is a PNAS Direct Submission. (nuclear protein in testis), giving rise to an incurable fatal sub- Freely available online through the PNAS open access option. type of squamous carcinoma and in some cases tumors of other Data deposition: The crystal structures reported in this paper have been deposited in the tissue origin (13). Importantly, BETs play a critical role in tu- Protein Data Bank, www.pdb.org (4MR3–4MR6). Microarray data have been deposited in the Gene Expression Omnibus (GEO) database, www.ncbi.nlm.nih.gov/geo (accession no. morigenesis also outside NMCs by driving the expression of GSE51143). genes that are essential for tumor growth and survival, such as 1 To whom correspondence may be addressed. E-mail: panagis.fi[email protected]. c-Myc (14) and Aurora B (15). The potent pan-BET inhibitors uk or [email protected]. + fi ( )-JQ1 and GSK1210151A (I-BET151) have exhibited signi cant This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. antitumor activity in murine models of NUT midline carcinoma 1073/pnas.1310658110/-/DCSupplemental. 19754–19759 | PNAS | December 3, 2013 | vol. 110 | no. 49 www.pnas.org/cgi/doi/10.1073/pnas.1310658110 Downloaded by guest on October 1, 2021 o ΔTm ( C) A RVX-208: R = -O(CH22 ) OH B BRD2/BD2 BRD3/BD2 R RVX-OH: R = -OH BRD3/BD1 > 4 BRD4/BD1 RVX-H: R = -H BRD4/BD2 BRD2/BD1 BRDT 3 - 4 /BD1 O N BRDT/BD2 2 - 3 1 - 2 FALZ GCN5L2 0 - 1 BAZ1A CECR2 PCAF NH EP300 < 0 CREBBP fi BRD8B Fig. 1. In vitro selectivity pro le of RVX-208. (A) WDR9/BD2 BRD8B PB1/BD1 PB1/BD3 /BD1 PB1/BD2 PHIP/BD2 /BD2 Structure of the inhibitor RVX-208 and its precursor OO PB1/BD4 BRWD3/BD2 ASH1L PB1/BD5 RVX-OH. (B) Selectivity of RVX-208 within the human C BAZ1B SMARCA2A BRD9 bromodomain family determined using a thermal 100 RVX-208 SMARCA2B BRD7 Δ obs μ BD1 PB1/BD6 SMARCA4 shift assay. Temperature shifts ( Tm in °C, at 10 M 75 BRPF3 BRPF1B BRWD3/BD1 compound concentration) are shown as spheres as BD2 BRD1 BRPF1A ATAD2 PHIP/BD1 50 RVX-OH KIAA1240 WDR9/BD1 indicated in the Inset. Screened proteins are shown MLL BD1 TRIM66 TRIM28 PRKCBP1 in bold. (C) Competitive displacement of a tetra- 25 BD2 BAZ2A TRIM33B BAZ2B ZMYND11 TAF1/BD1 acetylated histone H4 peptide (H4 – K5 /K8 / Inhibition (%) 1 20 ac ac 0 TRIM33A TIF1α SP110C TAF1L/BD1 K12ac/K16ac) from BD1 and BD2 of BRD3 using RVX- SP110A TAF1/BD2 -7 -6 -5 -4 SP100 TAF1L/BD2 208 or RVX-OH (as indicated in the Inset) in a bead- [compound] (log(M)) SP140 LOC93349 based proximity assay (ALPHA assay). (D) Isothermal D E titration calorimetry (ITC) binding study. Data col- 0.0 0.00 lected against the bromodomains of BRD3, showing raw injection heats for titrations of protein (BD1 or 0 0 BD2) into compound. The Inset shows the normal- -0.05 -1 -0.1 -2 ized binding enthalpies corrected for the heat of -2 BD1 -4 protein dilution as a function of binding site satu- cal/sec) -3 fi cal/sec) RVX-208 ration (symbols as indicated in the gure). Solid lines μ -6 -0.10 -4 μ RVX-OH represent a nonlinear least squares fit using a single- P ( -8 P ( BD2 Δ BD1 -5 -0.2 Δ -10 site binding model. (E) Isothermal titration calorimetry kcal/mole of injectant RVX-208 BD2 -6 (ITC) evaluation of RVX-208 and RVX-OH against the RVX-OH kcal/mole of injectant -0.15 -12 01234 bromodomains of BRD4. Data have been corrected BRD3 Molar Ratio BRD4 01234 Molar Ratio and displayed as described in D. All ITC titrations were BIOCHEMISTRY 0 1020304050607080 -0.3 0 10203040506070 carried out in 50 mM Hepes, pH 7.5 (at 25 °C), 150 mM Time (min) Time (min) NaCl and 15 °C while stirring at 1,000 rpm. to study its role regulating BET-dependent transcription. In- minor changes (Fig. S1C) and to study its interaction with human terestingly, we found that RVX-208 is specificforBETbromodo- BRD proteins.
Load more

Recommended publications
  • Genomic Correlates of Relationship QTL Involved in Fore- Versus Hind Limb Divergence in Mice
    Loyola University Chicago Loyola eCommons Biology: Faculty Publications and Other Works Faculty Publications 2013 Genomic Correlates of Relationship QTL Involved in Fore- Versus Hind Limb Divergence in Mice Mihaela Palicev Gunter P. Wagner James P. Noonan Benedikt Hallgrimsson James M. Cheverud Loyola University Chicago, [email protected] Follow this and additional works at: https://ecommons.luc.edu/biology_facpubs Part of the Biology Commons Recommended Citation Palicev, M, GP Wagner, JP Noonan, B Hallgrimsson, and JM Cheverud. "Genomic Correlates of Relationship QTL Involved in Fore- Versus Hind Limb Divergence in Mice." Genome Biology and Evolution 5(10), 2013. This Article is brought to you for free and open access by the Faculty Publications at Loyola eCommons. It has been accepted for inclusion in Biology: Faculty Publications and Other Works by an authorized administrator of Loyola eCommons. For more information, please contact [email protected]. This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License. © Palicev et al., 2013. GBE Genomic Correlates of Relationship QTL Involved in Fore- versus Hind Limb Divergence in Mice Mihaela Pavlicev1,2,*, Gu¨ nter P. Wagner3, James P. Noonan4, Benedikt Hallgrı´msson5,and James M. Cheverud6 1Konrad Lorenz Institute for Evolution and Cognition Research, Altenberg, Austria 2Department of Pediatrics, Cincinnati Children‘s Hospital Medical Center, Cincinnati, Ohio 3Yale Systems Biology Institute and Department of Ecology and Evolutionary Biology, Yale University 4Department of Genetics, Yale University School of Medicine 5Department of Cell Biology and Anatomy, The McCaig Institute for Bone and Joint Health and the Alberta Children’s Hospital Research Institute for Child and Maternal Health, University of Calgary, Calgary, Canada 6Department of Anatomy and Neurobiology, Washington University *Corresponding author: E-mail: [email protected].
    [Show full text]
  • A Cell Line P53 Mutation Type UM
    A Cell line p53 mutation Type UM-SCC 1 wt UM-SCC5 Exon 5, 157 GTC --> TTC Missense mutation by transversion (Valine --> Phenylalanine UM-SCC6 wt UM-SCC9 wt UM-SCC11A wt UM-SCC11B Exon 7, 242 TGC --> TCC Missense mutation by transversion (Cysteine --> Serine) UM-SCC22A Exon 6, 220 TAT --> TGT Missense mutation by transition (Tyrosine --> Cysteine) UM-SCC22B Exon 6, 220 TAT --> TGT Missense mutation by transition (Tyrosine --> Cysteine) UM-SCC38 Exon 5, 132 AAG --> AAT Missense mutation by transversion (Lysine --> Asparagine) UM-SCC46 Exon 8, 278 CCT --> CGT Missense mutation by transversion (Proline --> Alanine) B 1 Supplementary Methods Cell Lines and Cell Culture A panel of ten established HNSCC cell lines from the University of Michigan series (UM-SCC) was obtained from Dr. T. E. Carey at the University of Michigan, Ann Arbor, MI. The UM-SCC cell lines were derived from eight patients with SCC of the upper aerodigestive tract (supplemental Table 1). Patient age at tumor diagnosis ranged from 37 to 72 years. The cell lines selected were obtained from patients with stage I-IV tumors, distributed among oral, pharyngeal and laryngeal sites. All the patients had aggressive disease, with early recurrence and death within two years of therapy. Cell lines established from single isolates of a patient specimen are designated by a numeric designation, and where isolates from two time points or anatomical sites were obtained, the designation includes an alphabetical suffix (i.e., "A" or "B"). The cell lines were maintained in Eagle's minimal essential media supplemented with 10% fetal bovine serum and penicillin/streptomycin.
    [Show full text]
  • CD56+ T-Cells in Relation to Cytomegalovirus in Healthy Subjects and Kidney Transplant Patients
    CD56+ T-cells in Relation to Cytomegalovirus in Healthy Subjects and Kidney Transplant Patients Institute of Infection and Global Health Department of Clinical Infection, Microbiology and Immunology Thesis submitted in accordance with the requirements of the University of Liverpool for the degree of Doctor in Philosophy by Mazen Mohammed Almehmadi December 2014 - 1 - Abstract Human T cells expressing CD56 are capable of tumour cell lysis following activation with interleukin-2 but their role in viral immunity has been less well studied. The work described in this thesis aimed to investigate CD56+ T-cells in relation to cytomegalovirus infection in healthy subjects and kidney transplant patients (KTPs). Proportions of CD56+ T cells were found to be highly significantly increased in healthy cytomegalovirus-seropositive (CMV+) compared to cytomegalovirus-seronegative (CMV-) subjects (8.38% ± 0.33 versus 3.29%± 0.33; P < 0.0001). In donor CMV-/recipient CMV- (D-/R-)- KTPs levels of CD56+ T cells were 1.9% ±0.35 versus 5.42% ±1.01 in D+/R- patients and 5.11% ±0.69 in R+ patients (P 0.0247 and < 0.0001 respectively). CD56+ T cells in both healthy CMV+ subjects and KTPs expressed markers of effector memory- RA T-cells (TEMRA) while in healthy CMV- subjects and D-/R- KTPs the phenotype was predominantly that of naïve T-cells. Other surface markers, CD8, CD4, CD58, CD57, CD94 and NKG2C were expressed by a significantly higher proportion of CD56+ T-cells in healthy CMV+ than CMV- subjects. Functional studies showed levels of pro-inflammatory cytokines IFN-γ and TNF-α, as well as granzyme B and CD107a were significantly higher in CD56+ T-cells from CMV+ than CMV- subjects following stimulation with CMV antigens.
    [Show full text]
  • ARID5B As a Critical Downstream Target of the TAL1 Complex That Activates the Oncogenic Transcriptional Program and Promotes T-Cell Leukemogenesis
    Downloaded from genesdev.cshlp.org on October 10, 2021 - Published by Cold Spring Harbor Laboratory Press ARID5B as a critical downstream target of the TAL1 complex that activates the oncogenic transcriptional program and promotes T-cell leukemogenesis Wei Zhong Leong,1 Shi Hao Tan,1 Phuong Cao Thi Ngoc,1 Stella Amanda,1 Alice Wei Yee Yam,1 Wei-Siang Liau,1 Zhiyuan Gong,2 Lee N. Lawton,1 Daniel G. Tenen,1,3,4 and Takaomi Sanda1,4 1Cancer Science Institute of Singapore, National University of Singapore, 117599 Singapore; 2Department of Biological Sciences, National University of Singapore, 117543 Singapore; 3Harvard Medical School, Boston, Massachusetts 02215, USA; 4Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, 117599 Singapore The oncogenic transcription factor TAL1/SCL induces an aberrant transcriptional program in T-cell acute lym- phoblastic leukemia (T-ALL) cells. However, the critical factors that are directly activated by TAL1 and contribute to T-ALL pathogenesis are largely unknown. Here, we identified AT-rich interactive domain 5B (ARID5B) as a col- laborating oncogenic factor involved in the transcriptional program in T-ALL. ARID5B expression is down-regulated at the double-negative 2–4 stages in normal thymocytes, while it is induced by the TAL1 complex in human T-ALL cells. The enhancer located 135 kb upstream of the ARID5B gene locus is activated under a superenhancer in T-ALL cells but not in normal T cells. Notably, ARID5B-bound regions are associated predominantly with active tran- scription. ARID5B and TAL1 frequently co-occupy target genes and coordinately control their expression.
    [Show full text]
  • Mutational Landscape Differences Between Young-Onset and Older-Onset Breast Cancer Patients Nicole E
    Mealey et al. BMC Cancer (2020) 20:212 https://doi.org/10.1186/s12885-020-6684-z RESEARCH ARTICLE Open Access Mutational landscape differences between young-onset and older-onset breast cancer patients Nicole E. Mealey1 , Dylan E. O’Sullivan2 , Joy Pader3 , Yibing Ruan3 , Edwin Wang4 , May Lynn Quan1,5,6 and Darren R. Brenner1,3,5* Abstract Background: The incidence of breast cancer among young women (aged ≤40 years) has increased in North America and Europe. Fewer than 10% of cases among young women are attributable to inherited BRCA1 or BRCA2 mutations, suggesting an important role for somatic mutations. This study investigated genomic differences between young- and older-onset breast tumours. Methods: In this study we characterized the mutational landscape of 89 young-onset breast tumours (≤40 years) and examined differences with 949 older-onset tumours (> 40 years) using data from The Cancer Genome Atlas. We examined mutated genes, mutational load, and types of mutations. We used complementary R packages “deconstructSigs” and “SomaticSignatures” to extract mutational signatures. A recursively partitioned mixture model was used to identify whether combinations of mutational signatures were related to age of onset. Results: Older patients had a higher proportion of mutations in PIK3CA, CDH1, and MAP3K1 genes, while young- onset patients had a higher proportion of mutations in GATA3 and CTNNB1. Mutational load was lower for young- onset tumours, and a higher proportion of these mutations were C > A mutations, but a lower proportion were C > T mutations compared to older-onset tumours. The most common mutational signatures identified in both age groups were signatures 1 and 3 from the COSMIC database.
    [Show full text]
  • Multiple Roles for Unc-53/Nav2 in Cell Migration, Trafficking and Innate Immunity in Caenorhabditis Elegans
    MULTIPLE ROLES FOR UNC-53/NAV2 IN CELL MIGRATION, TRAFFICKING AND INNATE IMMUNITY IN CAENORHABDITIS ELEGANS by Kristopher Lee Schmidt M.Sc., University of British Columbia, 2005 B.Sc., Trinity Western University, 2001 THESIS SUBMITTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY in the Department of Molecular Biology and Biochemistry Faculty of Science © Kristopher Lee Schmidt 2012 SIMON FRASER UNIVERSITY Summer 2012 All rights reserved. However, in accordance with the Copyright Act of Canada, this work may be reproduced, without authorization, under the conditions for Fair Dealing. Therefore, limited reproduction of this work for the purposes of private study, research, criticism, review and news reporting is likely to be in accordance with the law, particularly if cited appropriately [Type a quotei from the document or the summary of an interesting point. APPROVAL Name: Kristopher Lee Schmidt Degree: Doctor of Philosophy Title of Thesis: Multiple roles for UNC-53/NAV2 in cell migration, trafficking, and innate immunity in Caenorhabditis elegans. Examining Committee: Chair: Dr. Barry Honda, Ph.D. Dr. Eve Stringham, Ph.D. Professor, Department of Molecular Biology Co-Senior Supervisor and Biochemistry Professor, Department of Biology, Trinity Associate Professor, Department of Western University __________________________________ __________________________________ Dr. Nancy Hawkins, Ph.D. Dr. Christopher Beh, Ph.D. Senior Supervisor Supervisor Associate Professor, Department of Molecular Associate Professor, Department of Molecular Biology and Biochemistry Biology and Biochemistry __________________________________ __________________________________ Dr. Nicholas Harden, Ph.D. Dr. Harald Hutter, Ph.D. Supervisor Internal Examiner Associate Professor, Department of Molecular Professor, Department of Biological Sciences Biology and Biochemistry __________________________________ __________________________________ Dr.
    [Show full text]
  • MYC-Containing Amplicons in Acute Myeloid Leukemia: Genomic Structures, Evolution, and Transcriptional Consequences
    Leukemia (2018) 32:2152–2166 https://doi.org/10.1038/s41375-018-0033-0 ARTICLE Acute myeloid leukemia Corrected: Correction MYC-containing amplicons in acute myeloid leukemia: genomic structures, evolution, and transcriptional consequences 1 1 2 2 1 Alberto L’Abbate ● Doron Tolomeo ● Ingrid Cifola ● Marco Severgnini ● Antonella Turchiano ● 3 3 1 1 1 Bartolomeo Augello ● Gabriella Squeo ● Pietro D’Addabbo ● Debora Traversa ● Giulia Daniele ● 1 1 3 3 4 Angelo Lonoce ● Mariella Pafundi ● Massimo Carella ● Orazio Palumbo ● Anna Dolnik ● 5 5 6 2 7 Dominique Muehlematter ● Jacqueline Schoumans ● Nadine Van Roy ● Gianluca De Bellis ● Giovanni Martinelli ● 3 4 8 1 Giuseppe Merla ● Lars Bullinger ● Claudia Haferlach ● Clelia Tiziana Storlazzi Received: 4 August 2017 / Revised: 27 October 2017 / Accepted: 13 November 2017 / Published online: 22 February 2018 © The Author(s) 2018. This article is published with open access Abstract Double minutes (dmin), homogeneously staining regions, and ring chromosomes are vehicles of gene amplification in cancer. The underlying mechanism leading to their formation as well as their structure and function in acute myeloid leukemia (AML) remain mysterious. We combined a range of high-resolution genomic methods to investigate the architecture and expression pattern of amplicons involving chromosome band 8q24 in 23 cases of AML (AML-amp). This 1234567890();,: revealed that different MYC-dmin architectures can coexist within the same leukemic cell population, indicating a step-wise evolution rather than a single event origin, such as through chromothripsis. This was supported also by the analysis of the chromothripsis criteria, that poorly matched the model in our samples. Furthermore, we found that dmin could evolve toward ring chromosomes stabilized by neocentromeres.
    [Show full text]
  • Genome-Wide Screen of Cell-Cycle Regulators in Normal and Tumor Cells
    bioRxiv preprint doi: https://doi.org/10.1101/060350; this version posted June 23, 2016. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Genome-wide screen of cell-cycle regulators in normal and tumor cells identifies a differential response to nucleosome depletion Maria Sokolova1, Mikko Turunen1, Oliver Mortusewicz3, Teemu Kivioja1, Patrick Herr3, Anna Vähärautio1, Mikael Björklund1, Minna Taipale2, Thomas Helleday3 and Jussi Taipale1,2,* 1Genome-Scale Biology Program, P.O. Box 63, FI-00014 University of Helsinki, Finland. 2Science for Life laboratory, Department of Biosciences and Nutrition, Karolinska Institutet, SE- 141 83 Stockholm, Sweden. 3Science for Life laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden To identify cell cycle regulators that enable cancer cells to replicate DNA and divide in an unrestricted manner, we performed a parallel genome-wide RNAi screen in normal and cancer cell lines. In addition to many shared regulators, we found that tumor and normal cells are differentially sensitive to loss of the histone genes transcriptional regulator CASP8AP2. In cancer cells, loss of CASP8AP2 leads to a failure to synthesize sufficient amount of histones in the S-phase of the cell cycle, resulting in slowing of individual replication forks. Despite this, DNA replication fails to arrest, and tumor cells progress in an elongated S-phase that lasts several days, finally resulting in death of most of the affected cells.
    [Show full text]
  • ARID5B Influences Anti-Metabolite Drug Sensitivity and Prognosis of Acute Lymphoblastic Leukemia
    Author Manuscript Published OnlineFirst on October 1, 2019; DOI: 10.1158/1078-0432.CCR-19-0190 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. ARID5B influences antimetabolite drug sensitivity and prognosis of acute lymphoblastic leukemia Heng Xu1,2*, Xujie Zhao2*, Deepa Bhojwani3, Shuyu E2, Charnise Goodings2, Hui Zhang4,2, Nita L. Seibel5, Wentao Yang2, Chunliang Li6, William L. Carroll7, William Evans2,8, Jun J. Yang2,8 1Department of Laboratory Medicine, Precision Medicine Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China. 2Department of Pharmaceutical Sciences, St. Jude Children’s Research Hospital, Memphis, Tennessee, USA. 3Division of Hematology, Oncology, Blood and Marrow Transplantation, Children's Hospital Los Angeles, Los Angeles, California, USA. 4Department of Pediatric Hematology and Oncology, Guangzhou Women and Children's Medical Center, Guangzhou, Guangdong, China. 5Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland, USA. 6Department of Tumor Cell Biology, St. Jude Children’s Research Hospital, Memphis, Tennessee, USA. 7Departments of Pediatrics and Pathology, New York University Langone Medical Center, New York, New York, USA. 8Hematological Malignancies Program, St. Jude Children’s Research Hospital, Memphis, Tennessee, USA Running title: ARID5B and drug resistance in ALL Keywords: acute lymphoblastic leukemia, ARID5B, p21, relapse, antimetabolite drug resistance *these authors contributed equally to this work. Financial support: This work was supported by the National Institutes of Health (GM118578, CA021765 and GM115279), the American Lebanese Syrian Associated Charities of St. Jude Children’s Research Hospital, and the Specialized Center of Research of Leukemia and Lymphoma Society (7010-14). Corresponding author: Jun J.
    [Show full text]
  • A Yeast Phenomic Model for the Influence of Warburg Metabolism on Genetic Buffering of Doxorubicin Sean M
    Santos and Hartman Cancer & Metabolism (2019) 7:9 https://doi.org/10.1186/s40170-019-0201-3 RESEARCH Open Access A yeast phenomic model for the influence of Warburg metabolism on genetic buffering of doxorubicin Sean M. Santos and John L. Hartman IV* Abstract Background: The influence of the Warburg phenomenon on chemotherapy response is unknown. Saccharomyces cerevisiae mimics the Warburg effect, repressing respiration in the presence of adequate glucose. Yeast phenomic experiments were conducted to assess potential influences of Warburg metabolism on gene-drug interaction underlying the cellular response to doxorubicin. Homologous genes from yeast phenomic and cancer pharmacogenomics data were analyzed to infer evolutionary conservation of gene-drug interaction and predict therapeutic relevance. Methods: Cell proliferation phenotypes (CPPs) of the yeast gene knockout/knockdown library were measured by quantitative high-throughput cell array phenotyping (Q-HTCP), treating with escalating doxorubicin concentrations under conditions of respiratory or glycolytic metabolism. Doxorubicin-gene interaction was quantified by departure of CPPs observed for the doxorubicin-treated mutant strain from that expected based on an interaction model. Recursive expectation-maximization clustering (REMc) and Gene Ontology (GO)-based analyses of interactions identified functional biological modules that differentially buffer or promote doxorubicin cytotoxicity with respect to Warburg metabolism. Yeast phenomic and cancer pharmacogenomics data were integrated to predict differential gene expression causally influencing doxorubicin anti-tumor efficacy. Results: Yeast compromised for genes functioning in chromatin organization, and several other cellular processes are more resistant to doxorubicin under glycolytic conditions. Thus, the Warburg transition appears to alleviate requirements for cellular functions that buffer doxorubicin cytotoxicity in a respiratory context.
    [Show full text]
  • Deletions of IKZF1 and SPRED1 Are Associated with Poor Prognosis in A
    Leukemia (2014) 28, 302–310 & 2014 Macmillan Publishers Limited All rights reserved 0887-6924/14 www.nature.com/leu ORIGINAL ARTICLE Deletions of IKZF1 and SPRED1 are associated with poor prognosis in a population-based series of pediatric B-cell precursor acute lymphoblastic leukemia diagnosed between 1992 and 2011 L Olsson1, A Castor2, M Behrendtz3, A Biloglav1, E Forestier4, K Paulsson1 and B Johansson1,5 Despite the favorable prognosis of childhood acute lymphoblastic leukemia (ALL), a substantial subset of patients relapses. As this occurs not only in the high risk but also in the standard/intermediate groups, the presently used risk stratification is suboptimal. The underlying mechanisms for treatment failure include the presence of genetic changes causing insensitivity to the therapy administered. To identify relapse-associated aberrations, we performed single-nucleotide polymorphism array analyses of 307 uniformly treated, consecutive pediatric ALL cases accrued during 1992–2011. Recurrent aberrations of 14 genes in patients who subsequently relapsed or had induction failure were detected. Of these, deletions/uniparental isodisomies of ADD3, ATP10A, EBF1, IKZF1, PAN3, RAG1, SPRED1 and TBL1XR1 were significantly more common in B-cell precursor ALL patients who relapsed compared with those remaining in complete remission. In univariate analyses, age (X10 years), white blood cell counts (4100 Â 109/l), t(9;22)(q34;q11), MLL rearrangements, near-haploidy and deletions of ATP10A, IKZF1, SPRED1 and the pseudoautosomal 1 regions on Xp/Yp were significantly associated with decreased 10-year event-free survival, with IKZF1 abnormalities being an independent risk factor in multivariate analysis irrespective of the risk group. Older age and deletions of IKZF1 and SPRED1 were also associated with poor overall survival.
    [Show full text]
  • Identification of the Molecular Mechanisms Underlying Dilated Cardiomyopathy Via Bioinformatic Analysis of Gene Expression Profiles
    EXPERIMENTAL AND THERAPEUTIC MEDICINE 13: 273-279, 2017 Identification of the molecular mechanisms underlying dilated cardiomyopathy via bioinformatic analysis of gene expression profiles HU ZHANG1, ZHUO YU2, JIANCHAO HE1, BAOTONG HUA2 and GUIMING ZHANG1 Departments of 1Cardiaovascular Surgery and 2Cardiology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650032, P.R. China Received March 26, 2015; Accepted April 21, 2016 DOI: 10.3892/etm.2016.3953 Abstract. In the present study, gene expression profiles of binding protein 3 (IGFBP3)], ‘muscle organ development’ patients with dilated cardiomyopathy (DCM) were re‑analyzed (SMAD7) and ‘regulation of cell migration’ [SMAD7, IGFBP3 with bioinformatics tools to investigate the molecular mecha- and insulin receptor (INSR)]. Notably, signal transducer and nisms underlying DCM. Gene expression dataset GSE3585 activator of transcription 3, SMAD7, INSR, CTGF, exportin 1, was downloaded from Gene Expression Omnibus, which IGFBP3 and phosphatidylinositol‑4,5‑bisphosphate 3‑kinase, included seven heart biopsy samples obtained from patients catalytic subunit alpha were hub nodes with the higher degree with DCM and five healthy controls. Differential analysis was in the PPI network. Therefore, the results of the present study performed using a Limma package in R to screen for differen- suggested that DEGs may alter the biological processes of tially expressed genes (DEGs). Functional enrichment analysis ‘nucleosome formation’, ‘cell adhesion’, ‘skeletal system devel- was subsequently conducted for DEGs using the Database opment’, ‘muscle organ development’ and ‘regulation of cell for Annotation, Visualization and Integration Discovery. A migration’ in the development of DCM. protein‑protein interaction (PPI) network was constructed using information from Search Tool for the Retrieval of Introduction Interacting Genes software.
    [Show full text]